Market Cap
€2.4b
Last Updated
2021/05/09 02:52 UTC
Data Sources
Company Financials +
Executive Summary
GVS S.p.A., together with its subsidiaries, produces and sells plastic filters and components for healthcare, life science, automotive, appliance, safety, and commercial and industrial filtration applications in Italy and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with outstanding track record.
Share Price & News
How has GVS's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine GVSM's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine GVSM's volatility change over the past year.
Market Performance
7 Day Return
-0.6%
GVSM
1.7%
GB Medical Equipment
2.1%
GB Market
1 Year Return
n/a
GVSM
3.0%
GB Medical Equipment
26.5%
GB Market
Return vs Industry: Insufficient data to determine how GVSM performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how GVSM performed against the UK Market.
Shareholder returns
| GVSM | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.6% | 1.7% | 2.1% |
| 30 Day | 3.1% | 12.5% | 3.3% |
| 90 Day | -12.9% | 5.4% | 9.1% |
| 1 Year | n/a | 4.9%3.0% | 32.1%26.5% |
| 3 Year | n/a | 25.4%18.3% | 12.8%-0.2% |
| 5 Year | n/a | 47.8%35.6% | 51.7%23.0% |
Long-Term Price Volatility Vs. Market
How volatile is GVS's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is GVS undervalued compared to its fair value and its price relative to the market?
39.3%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GVSM (€14.44) is trading below our estimate of fair value (€23.79)
Significantly Below Fair Value: GVSM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GVSM is good value based on its PE Ratio (24x) compared to the GB Medical Equipment industry average (49.5x).
PE vs Market: GVSM is good value based on its PE Ratio (24x) compared to the UK market (26.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GVSM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GVSM is overvalued based on its PB Ratio (7.7x) compared to the GB Medical Equipment industry average (3.8x).
Future Growth
How is GVS forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
2.9%
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GVSM's forecast earnings growth is above the savings rate (0.9%).
Earnings vs Market: Insufficient data to determine if GVSM's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GVSM's revenue (2.9% per year) is forecast to grow slower than the UK market (5.3% per year).
High Growth Revenue: GVSM's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GVSM's Return on Equity is forecast to be high in 3 years time
Past Performance
How has GVS performed over the past 5 years?
48.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GVSM has high quality earnings.
Growing Profit Margin: GVSM's current net profit margins (21.4%) are higher than last year (14.5%).
Past Earnings Growth Analysis
Earnings Trend: GVSM's earnings have grown significantly by 48% per year over the past 5 years.
Accelerating Growth: GVSM's earnings growth over the past year (135.5%) exceeds its 5-year average (48% per year).
Earnings vs Industry: GVSM earnings growth over the past year (135.5%) exceeded the Medical Equipment industry 13.8%.
Return on Equity
High ROE: GVSM's Return on Equity (32.2%) is considered high.
Financial Health
How is GVS's financial position?
Financial Position Analysis
Short Term Liabilities: GVSM's short term assets (€238.5M) exceed its short term liabilities (€85.7M).
Long Term Liabilities: GVSM's short term assets (€238.5M) exceed its long term liabilities (€84.0M).
Debt to Equity History and Analysis
Debt Level: GVSM's debt to equity ratio (36.8%) is considered satisfactory.
Reducing Debt: GVSM's debt to equity ratio has reduced from 135.1% to 36.8% over the past 5 years.
Debt Coverage: GVSM's debt is well covered by operating cash flow (127.6%).
Interest Coverage: GVSM's interest payments on its debt are well covered by EBIT (32.8x coverage).
Balance Sheet
Dividend
What is GVS current dividend yield, its reliability and sustainability?
0.95%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: GVSM's dividend (0.95%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.35%).
High Dividend: GVSM's dividend (0.95%) is low compared to the top 25% of dividend payers in the UK market (4.04%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether GVSM's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if GVSM's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (22.8%), GVSM's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: GVSM is not forecast to pay a dividend in 3 years.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
CEO
Massimo Scagliarini (55 yo)
no data
Tenure
Mr. Massimo Scagliarini serves as Chief Executive Officer and Director at GVS S.p.A. With over 35 years of experience, he has led the division operating in the medical sector and turn it into the most succ...
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: GVSM only recently listed within the past 12 months.
Top Shareholders
Company Information
GVS S.p.A.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: GVS S.p.A.
- Ticker: GVSM
- Exchange: BATS-CHIXE
- Founded: 1979
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €2.394b
- Shares outstanding: 175.00m
- Website: https://www.gvs.com
Number of Employees
Location
- GVS S.p.A.
- Via Roma 50
- Zola Predosa
- Bologna
- 40069
- Italy
Listings
Biography
GVS S.p.A., together with its subsidiaries, produces and sells plastic filters and components for healthcare, life science, automotive, appliance, safety, and commercial and industrial filtration applicati...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/05/09 02:52 |
| End of Day Share Price | 2021/05/04 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.